These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 24305533)

  • 21. Evolving features in type 3 Gaucher disease on long-term enzyme replacement therapy.
    Elstein D; Abrahamov A; Altarescu G; Zimran A
    Blood Cells Mol Dis; 2013 Feb; 50(2):140. PubMed ID: 23085428
    [No Abstract]   [Full Text] [Related]  

  • 22. RecTL: a complex allele of the glucocerebrosidase gene associated with a mild clinical course of Gaucher disease.
    Zimran A; Horowitz M
    Am J Med Genet; 1994 Mar; 50(1):74-8. PubMed ID: 8160756
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Congenital ichthyosis in severe type II Gaucher disease with a homozygous null mutation.
    Haverkaemper S; Marquardt T; Hausser I; Timme K; Kuehn T; Hertzberg C; Rossi R
    Neonatology; 2011; 100(2):194-7. PubMed ID: 21455010
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is the perinatal lethal form of Gaucher disease more common than classic type 2 Gaucher disease?
    Stone DL; van Diggelen OP; de Klerk JB; Gaillard JL; Niermeijer MF; Willemsen R; Tayebi N; Sidransky E
    Eur J Hum Genet; 1999; 7(4):505-9. PubMed ID: 10352942
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [From gene to disease; Gaucher disease].
    Hollak CE; Boot RG; Poorthuis BJ; Aerts JM
    Ned Tijdschr Geneeskd; 2005 Sep; 149(39):2163-6. PubMed ID: 16223076
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Type I Gaucher's disease with homozygous R463C mutation without neurological involvement.
    Bolaman Z; Kadikoylu G; Levi E; Barutca S; Temucin K
    Haematologia (Budap); 2002; 32(4):487-93. PubMed ID: 12803123
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gaucher disease in the neonate: a distinct Gaucher phenotype is analogous to a mouse model created by targeted disruption of the glucocerebrosidase gene.
    Sidransky E; Sherer DM; Ginns EI
    Pediatr Res; 1992 Oct; 32(4):494-8. PubMed ID: 1437405
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New perspectives in type 2 Gaucher disease.
    Sidransky E
    Adv Pediatr; 1997; 44():73-107. PubMed ID: 9265968
    [No Abstract]   [Full Text] [Related]  

  • 29. Gaucher type 2 disease: identification of a novel transversion mutation in a French-Irish patient.
    Choy FY; Humphries ML; Ben-Yoseph Y
    Am J Med Genet; 1998 Jun; 78(1):92-3. PubMed ID: 9637431
    [No Abstract]   [Full Text] [Related]  

  • 30. Gaucher disease with prenatal onset and perinatal death due to compound heterozygosity for the missense R131C and null Rec Nci I GBA mutations.
    Goebl A; Ferrier RA; Ferreira P; Pinto-Rojas A; Matshes E; Choy FY
    Pediatr Dev Pathol; 2011; 14(3):240-3. PubMed ID: 20946052
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacologic chaperoning as a strategy to treat Gaucher disease.
    Yu Z; Sawkar AR; Kelly JW
    FEBS J; 2007 Oct; 274(19):4944-50. PubMed ID: 17894779
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rational design and synthesis of highly potent pharmacological chaperones for treatment of N370S mutant Gaucher disease.
    Wang GN; Reinkensmeier G; Zhang SW; Zhou J; Zhang LR; Zhang LH; Butters TD; Ye XS
    J Med Chem; 2009 May; 52(10):3146-9. PubMed ID: 19397268
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Gaucher disease: clinical, genetic and therapeutic aspects].
    Germain DP
    Pathol Biol (Paris); 2004 Jul; 52(6):343-50. PubMed ID: 15261378
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Gaucher's disease and enzyme replacement therapy].
    Cornu F
    Ann Pharm Fr; 1998; 56(3):102-7. PubMed ID: 9770016
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An infant with type II Gaucher disease treated with enzyme replacement therapy.
    Ebihara G; Matsushita Y; Kirino M; Hikino S; Sato K
    Pediatr Int; 2022 Jan; 64(1):e14873. PubMed ID: 34847281
    [No Abstract]   [Full Text] [Related]  

  • 36. [Type 1 Gaucher disease in a pediatric patient: 12 year's evolution].
    García M; Casanova C; Chabás A; Viosca E; Martínez B
    Sangre (Barc); 1997 Jun; 42(3):227-9. PubMed ID: 9381267
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mesenteric and Mediastinal Lymphadenopathy in Egyptian Children With Gaucher Disease Types 1 and 3 Treated With Enzyme Replacement Therapy.
    Abdelwahab M; SeifEldien HM
    J Pediatr Hematol Oncol; 2015 Jul; 37(5):e316-22. PubMed ID: 25521082
    [TBL] [Abstract][Full Text] [Related]  

  • 38. How I treat Gaucher disease.
    Zimran A
    Blood; 2011 Aug; 118(6):1463-71. PubMed ID: 21670466
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiovascular fibrosis, hydrocephalus, ophthalmoplegia, and visceral involvement in an American child with Gaucher disease.
    Stone DL; Tayebi N; Coble C; Ginns EI; Sidransky E
    J Med Genet; 2000 Nov; 37(11):E40. PubMed ID: 11073549
    [No Abstract]   [Full Text] [Related]  

  • 40. Early initiation of high-dose oral ambroxol in combination with enzyme replacement therapy in a neuropathic Gaucher infant.
    Chu SY; Chien CC; Hwu WL; Wang PJ; Chien YH
    Blood Cells Mol Dis; 2020 Mar; 81():102402. PubMed ID: 31918384
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.